spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES
 

Bioclinica Introduces Oncology Rescue Studies Team

Dedicated specialists focus on at-risk trials, driving toward new Oncology therapies

More>>

 
phone +1 609-936-2896
email info@bioclinica.com
web www.bioclinica.com/
 

Bioclinica Launches Clean Patient Optics to Accelerate Database Lock and Clinical Trial Timelines

Empowers sponsors and CROs with insights on study health

More>>

 
phone +1 609-936-2896
email info@bioclinica.com
web www.bioclinica.com/
 

Elsevier launches solution to accelerate drug discovery through comprehensive prediction and assessment of drug-drug interactions

New PharmaPendium solution comes with DDI risk calculator enabling earlier and more complete risk mitigation strategies for potential drug-drug interactions

More>>

 
phone +44 20 7424 4200
web https://www.elsevier.com/
email Elsevier Limited (Corporate Office), 125 London Wall, London, EC2Y 5AS, UK
 

Natoli Engineering Company Announces Metal Detectable Dust Cups and Bellows

Natoli Engineering Company, Inc announces an addition to their Tablet Compression Accessories Catalog—metal detectable dust cups and bellows.

More>>

 
phone +1 636 926 8900
email info@natoli.com
web www.natoli.com
email 28 Research Park Circle, Saint Charles, MO 63304, US
 

Aptar Pharma Extends its Child-Resistant Nasal Pump Manufacturing Capabilities in North America

Aptar Pharma announces the installation of manufacturing capacity for its Child-Resistant and Senior-Friendly Classic Nasal Pump in their Congers, NY site

More>>

 
phone +33 (0)13 917 2020
email info.pharma@aptar.com
web www.aptar.com/pharma
email 36-38 Rue de la Princesse, 78431 Louveciennes
 

Chiltern Acquires Japanese Clinical Research Organization Integrated Development Associates Co. Ltd.

Chiltern, a leading global contract research organization, has acquired Integrated Development Associates Co. Ltd. (IDA), a CRO specializing in integrating Japan and Asia into global drug development.

More>>

 
phone UK:+44(0)1753 512 000; US:+1 (423) 968 9533
email info@chiltern.com
web www.chiltern.com
email UK: 171 Bath Road, Slough, Berkshire, SL1 4AA. US: 3147 S. 17th Street, Suite 300 Wilmington, NC 28412.
 

PRISYM ID to Exhibit at the Clinical Trials Supply Nordics Event

PRISYM ID, leading provider of labelling solutions for the life sciences industries, is exhibiting at The Clinical Trial Supply Event in Copenhagen, Denmark on the 7/8th June 2017, on stand 6

More>>

 
phone +44 (0) 118 936 4400
email info@prisymid.com
web www.prisymid.com/
email TECH House, Oaklands Business Centre, Oaklands Park, Wokingham, Berkshire, RG41 2FD, UK
 

Wickham Laboratories Announces Upcoming Webinar on In-Vitro Alternatives

Join us for a free webinar to discuss the challenges of transitioning from in-vivo to in-vitro methods

More>>

 
phone +44 (0)1329 226600
email marketing@wickhamlabs.co.uk
web www.wickhamlabs.co.uk/
email Hoeford Point, Barwell Lane, Gosport, Hampshire, PO13 0AU, United Kingdom
 

Quanterix Launches the First Comprehensive Multiplex Panel to Study Traumatic Brain Injury Severity

New panel offers unmatched sensitivity to simultaneously measure four proven neurological protein biomarkers in blood and cerebrospinal fluid within a single test

More>>

 
phone 617-301-9400
email info@quanterix.com
web www.quanterix.com
email 113 Hartwell Ave, Lexington, MA 02421
 

Owlstone Medicals ReCIVA Named Invention of the Year in Top 50 Digital Health Awards

Awards recognize exceptional progress in bringing technological advancements to healthcare

More>>

 
phone +44 (0)1223 428200
web www.owlstonenanotech.com
email Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK
 
 
spacer
News and Press Releases

Data at ASH 2016 Show Strong, Lasting Efficacy of Imbruvica® (ibrutinib) Through Five Years of Treatment for Chronic Lymphocytic Leukaemia (CLL)


More info >>


White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

Industry Events

Outsourcing in Clinical Trials Medical Devices 2017

27-28 June 2017, Santa Clara, CA

OCT Medical Devices moved to Irvine, California for the first year in 2016, and we are pleased to say it proved a resounding success. As the only event to cater for the Southern California Medical device hub in Irvine, it brought together a variety of medical device companies of all sizes, including Medtronic, Edwards Lifesciences, Onciomed, Inc and St Jude Medical.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement